Actively Recruiting
Diabetes Registry Graz for Biomarker Research
Led by Medical University of Graz · Updated on 2023-07-07
2000
Participants Needed
1
Research Sites
1006 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.
CONDITIONS
Official Title
Diabetes Registry Graz for Biomarker Research
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 99 years
- Written informed consent given
- Diagnosis of at least one of the following: Type 1 diabetes, Type 2 diabetes, Type 3 diabetes, Maturity onset diabetes of young (MODY), Late onset diabetes of the adult (LADA), obesity (BMI > 30 kg/m2), or lipid metabolism disorder
You will not qualify if you...
- No written informed consent
- Not willing to participate in this registry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Graz
Graz, Austria, 8010
Actively Recruiting
Research Team
C
Caren Sourij, MD
CONTACT
H
Harald Sourij, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
7
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here